The Crucible of Innovation: Forging the Future of Cell & Gene Therapy Manufacturing Amidst Unprecedented Change (2025)
The Cell and Gene Therapy (CGT) landscape is currently a crucible – a volatile, intensely challenging, yet profoundly transformative environment where the future of medicine is being forged. The year 2025 has already unleashed a torrent of regulatory shake-ups, groundbreaking technological advancements, significant capital realignments, and intense market pressures. For every therapy developer, Contract Development […]